Cargando…

Guideline for the management of neurogenic bowel dysfunction in spinal cord injury/disease

INTRODUCTION: Almost all people with spinal cord injury/disease (SCI/D) suffer from neurogenic bowel dysfunction (NBD), with a considerable impact on quality of life. The Association of the Scientific Medical Societies in Germany (AWMF e.V.) guideline for NBD in SCI/D aims to provide practice-orient...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurze, Ines, Geng, Veronika, Böthig, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948006/
https://www.ncbi.nlm.nih.gov/pubmed/35332274
http://dx.doi.org/10.1038/s41393-022-00786-x
_version_ 1784674570071965696
author Kurze, Ines
Geng, Veronika
Böthig, Ralf
author_facet Kurze, Ines
Geng, Veronika
Böthig, Ralf
author_sort Kurze, Ines
collection PubMed
description INTRODUCTION: Almost all people with spinal cord injury/disease (SCI/D) suffer from neurogenic bowel dysfunction (NBD), with a considerable impact on quality of life. The Association of the Scientific Medical Societies in Germany (AWMF e.V.) guideline for NBD in SCI/D aims to provide practice-oriented support for the care of patients with NBD resulting from congenital or aquired SCI/D. The guideline describes the diagnosis and bowel management of NBD in people with SCI/D. Thus, treatment processes in acute medical care and rehabilitation as well as for lifelong aftercare are presented. METHODS: The present guideline was developed under the leadership of the German-speaking Medical Society for Paraplegiology in a multiprofessional interdisciplinary guideline team. To exceed the level of expert recommendations, consensus was reached within the framework of a structured nominal group process in defined steps under neutral moderation considering the criteria of the German guideline development instrument (DELBI). RESULTS: Individual bowel management must be developed on the basis of an adequate diagnosis and considering the different lesion types. Due to the multifactorial influenceability of the intestine and the individual neurological deficit, a simple to-do checklist is not effective. Various and complex bowel management programmes are the basis of the treatment of NBD. CONCLUSIONS: Guidelines can only be successful in so far as they are applied in everyday life. Of course, the selection and application of the measures described must always take into consideration the individual situation of the person concerned, and the correct application is always a prerequisite for success.
format Online
Article
Text
id pubmed-8948006
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-89480062022-03-25 Guideline for the management of neurogenic bowel dysfunction in spinal cord injury/disease Kurze, Ines Geng, Veronika Böthig, Ralf Spinal Cord Article INTRODUCTION: Almost all people with spinal cord injury/disease (SCI/D) suffer from neurogenic bowel dysfunction (NBD), with a considerable impact on quality of life. The Association of the Scientific Medical Societies in Germany (AWMF e.V.) guideline for NBD in SCI/D aims to provide practice-oriented support for the care of patients with NBD resulting from congenital or aquired SCI/D. The guideline describes the diagnosis and bowel management of NBD in people with SCI/D. Thus, treatment processes in acute medical care and rehabilitation as well as for lifelong aftercare are presented. METHODS: The present guideline was developed under the leadership of the German-speaking Medical Society for Paraplegiology in a multiprofessional interdisciplinary guideline team. To exceed the level of expert recommendations, consensus was reached within the framework of a structured nominal group process in defined steps under neutral moderation considering the criteria of the German guideline development instrument (DELBI). RESULTS: Individual bowel management must be developed on the basis of an adequate diagnosis and considering the different lesion types. Due to the multifactorial influenceability of the intestine and the individual neurological deficit, a simple to-do checklist is not effective. Various and complex bowel management programmes are the basis of the treatment of NBD. CONCLUSIONS: Guidelines can only be successful in so far as they are applied in everyday life. Of course, the selection and application of the measures described must always take into consideration the individual situation of the person concerned, and the correct application is always a prerequisite for success. Nature Publishing Group UK 2022-03-25 2022 /pmc/articles/PMC8948006/ /pubmed/35332274 http://dx.doi.org/10.1038/s41393-022-00786-x Text en © The Author(s), under exclusive licence to International Spinal Cord Society 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Kurze, Ines
Geng, Veronika
Böthig, Ralf
Guideline for the management of neurogenic bowel dysfunction in spinal cord injury/disease
title Guideline for the management of neurogenic bowel dysfunction in spinal cord injury/disease
title_full Guideline for the management of neurogenic bowel dysfunction in spinal cord injury/disease
title_fullStr Guideline for the management of neurogenic bowel dysfunction in spinal cord injury/disease
title_full_unstemmed Guideline for the management of neurogenic bowel dysfunction in spinal cord injury/disease
title_short Guideline for the management of neurogenic bowel dysfunction in spinal cord injury/disease
title_sort guideline for the management of neurogenic bowel dysfunction in spinal cord injury/disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948006/
https://www.ncbi.nlm.nih.gov/pubmed/35332274
http://dx.doi.org/10.1038/s41393-022-00786-x
work_keys_str_mv AT kurzeines guidelineforthemanagementofneurogenicboweldysfunctioninspinalcordinjurydisease
AT gengveronika guidelineforthemanagementofneurogenicboweldysfunctioninspinalcordinjurydisease
AT bothigralf guidelineforthemanagementofneurogenicboweldysfunctioninspinalcordinjurydisease